Reunion Neuroscience Inc. (REUN)
NASDAQ: REUN
· Real-Time Price · USD
1.12
-0.01 (-0.88%)
At close: Jul 31, 2023, 9:59 PM
Company Description
Field Trip Health Ltd. engages in the development and delivery of psychedelic- assisted therapies in North America.
The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; operates Field Trip Discovery, a drug development division that develops the next generation of psychedelic molecules; and provides ketamine-assisted therapy for the treatment of depression, anxiety, addiction, and other conditions.
Field Trip Health Ltd. was founded in 2008 and is headquartered in Toronto, Canada.
Reunion Neuroscience Inc.
| Country | CA |
| IPO Date | Oct 7, 2020 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 16 |
| CEO | Gregory T. Mayes |
Contact Details
Address: 30 Duncan Street Toronto, ON CA | |
| Website | https://www.fieldtriphealth.com |
Stock Details
| Ticker Symbol | REUN |
| Exchange | NASDAQ |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0001865482 |
| CUSIP Number | 76134G103 |
| ISIN Number | CA76134G1037 |
| Employer ID | 00-0000000 |
| SIC Code | 8000 |
Key Executives
| Name | Position |
|---|---|
| Gregory T. Mayes Esq., J.D. | Pres, Chief Executive Officer & Director |
| Curtis Weber | Chief Legal Officer |
| Edward F. Smith CPA | Chief Financial Officer |
| Mujeeb Jafferi | CO-Founder & Chief Operating Officer |
| Curtis Weber | Gen. Counsel |
| Dr. Michael Verbora M.B.A., M.D. | Senior Vice President & Medical Director |
| Dr. Nathan Bryson B.Sc., Ph.D. | Chief Science Officer |
| Dr. Robert Alexander M.D. | Chief Medical Officer & Senior Advisor |
| Hannan Fleiman | Co-Founder & Non-Independent Director |
| Matt Emmer | Director of Operations & Bus. Devel. |
| Stephan Cote | Head of Quality |
| Vicki Reed | Chief Growth Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 18, 2023 | 15-12G | Filing |
| Aug 01, 2023 | 6-K | Filing |
| Aug 01, 2023 | SC 13D/A | [Amend] Filing |
| Aug 01, 2023 | F-10POS | Filing |
| Aug 01, 2023 | S-8 POS | Filing |
| Aug 01, 2023 | S-8 POS | Filing |
| Aug 01, 2023 | 25-NSE | Filing |
| Jul 19, 2023 | 6-K | Filing |
| Jul 13, 2023 | 6-K | Filing |
| Jul 07, 2023 | 6-K | Filing |